Inhibition of human cytochrome P450 3A4 activity by zinc(II) ion

被引：7
|
作者：
Kim, JS
Yun, CH [1 ]
机构：
[1] Chonnam Natl Univ, Hormone Res Ctr, Kwangju 500757, South Korea
[2] Paichai Univ, AngioLab, Taejon 302735, South Korea
[3] Chonnam Natl Univ, Sch Biol Sci & Technol, Kwangju 500757, South Korea
来源：
TOXICOLOGY LETTERS | 2005年 / 156卷 / 03期
关键词：
cytochrome P450 3A4; Zn(II) ion; NADPH-cytochrome P450 reductase; cytochrome b(5); testosterone 6 beta-hydroxylation activity;
D O I：
10.1016/j.toxlet.2004.12.006
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
Effects of Zn2+ on the activity and conformation of cytochorome P450 3A4 (CYP3A4) were investigated. Zn2+ specifically inhibited the testosterone 6 beta-hydroxylation activity of CYP3A4 with an IC50 value of 27 mu M. Zn2+ inhibited the CO-binding spectra of CYP3A4 reduced by NADPH-cytochrome P450 reductase (CPR) and NADPH only in the presenceof b(5).Zn2+-induced conformational changes of CYP3A4 were monitored by CD and intrinsic fluorescence. Zn2+ showed no significant effects on the activity of CYP3A4 supported by tert-butyl hydroperoxide, an oxygen surrogate, and on the reduction of b(5) by CPR and NADPH. These results suggest that the inhibitory effects of Zn2+ come from preventing the stimulation of b(5) on CYP3A4 activity. (c) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：341 / 350
页数：10
相关论文
共 50 条
  • [21] Molecular modeling of cytochrome P450 3A4
    Szklarz, GD
    Halpert, JR
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1997, 11 (03) : 265 - 272
  • [22] RELATIONSHIP OF PASSIVE PERMEABILITY AND CYTOCHROME P450 (CYP) 3A4 INHIBITION
    Li, Ling
    Zhou, Julia
    Nouraldeen, Amr
    Wilson, Alan G. E.
    DRUG METABOLISM REVIEWS, 2014, 45 : 131 - 131
  • [23] In Vitro Inhibition of Cytochrome P450 3A4 by Aronia melanocarpa Constituents
    Braunlich, Marie
    Christensen, Hege
    Johannesen, Siri
    Slimestad, Rune
    Wangensteen, Helle
    Malterud, Karl E.
    Barsett, Hilde
    PLANTA MEDICA, 2013, 79 (02) : 137 - 141
  • [24] Increased inhibition of cytochrome P450 3A4 with the tablet formulation of posaconazole
    Petitcollin, A.
    Crochette, R.
    Tron, C.
    Verdier, M. -C.
    Boglione-Kerrien, C.
    Vigneau, C.
    Bellissant, E.
    Lemaitre, F.
    DRUG METABOLISM AND PHARMACOKINETICS, 2016, 31 (05) : 389 - 393
  • [25] Sertraline and cytochrome P450 3A4 in dysthymia
    Dunn, E
    Helpard, B
    Steiner, M
    BIOLOGICAL PSYCHIATRY, 1997, 41 : 116 - 116
  • [26] Molecular modeling of cytochrome P450 3A4
    Grazyna D. Szklarz
    James R. Halpert
    Journal of Computer-Aided Molecular Design, 1997, 11 : 265 - 272
  • [27] Molecular simulations of cytochrome P450 3A4
    Czapla, Luke
    Amaro, Rommie E.
    Kontoyianni, Maria
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [28] Biotransformation of zafirlukast by cytochrome P450 3A4
    Skordos, KW
    Yost, GS
    DRUG METABOLISM REVIEWS, 2003, 35 : 49 - 49
  • [29] Structural Dynamics of Cytochrome P450 3A4 in the Presence of Substrates and Cytochrome P450 Reductase
    Ducharme, Julie
    Sevrioukova, Irina F.
    Thibodeaux, Christopher J.
    Auclair, Karine
    BIOCHEMISTRY, 2021, 60 (28) : 2259 - 2271
  • [30] Determination of cytochrome P450 1A2 and cytochrome P450 3A4 induction in cryopreserved human hepatocytes
    Roymans, D
    Van Looveren, C
    Leone, A
    Parker, JB
    McMillian, M
    Johnson, MD
    Koganti, A
    Gilissen, R
    Silber, P
    Mannens, G
    Meuldermans, W
    BIOCHEMICAL PHARMACOLOGY, 2004, 67 (03) : 427 - 437
12345